Thu, Sep 18, 2014, 6:11 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • pourthechianti pourthechianti Jun 19, 2006 4:47 PM Flag

    Supergen Value

    This is just my opinion of the value of SUPG. I have tried to be conservative in the estimates and I will disclose that I am an owner of the stock.

    Nipent should be worth 2 times sales so I am valuing it at $40 million.

    Dacogen, if you assign a market for MDS of say conservatively $300 million annually.

    Montigen. Say the preclinical platform is worth approx. $15 million. I beleive I read that this is what it was purchased for.

    Cash. At the end of March the cash position was $49 million. Now with the mile stone payment of $20 million the cash position should be close to including current burn rate of $5 million per month. At this I arrive at a cash position of $55 million.

    The total value of the assets is $410 million divided by 55 million shares outstanding derives a per share value of $7.45.

    This is based only on my calculations which are just estimates. In summary, I think we are seeing a lot of market risk and pricing of the stock based on the overall market and not specific company value. I also have to believe that MGI would have to be looking at acquiring them at these values. MGI could offer $6 per share and get enough votes to pull of the deal.

    Constructive criticism open.

    Good luck to all.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.